Iconic 80s band suddenly cancels entire tour including LA stops: ‘Blue dot fever’

Swedish pop-rock duo Roxette has abruptly called off their entire North American tour scheduled for fall 2024, including key performances in cities like Los Angeles. The band, internationally renowned for hits such as "It Must Have Been Love" and "Listen to Your Heart," had planned a 40th anniversary tour across the United States and Canada. However, Live Nation US announced the cancellation last week, citing logistical difficulties and rising touring expenses as the primary reasons behind the decision.

Originally, the tour was set to launch on September 10 at Michigan’s Pine Knob Music Theatre and conclude on October 9 at the White River Amphitheatre in Washington. The lineup also featured notable 1980s artists Taylor Dayne and Nick Lowe. Fans who had secured tickets were notified of the cancellations and promised refunds, though international attendees faced additional challenges due to non-refundable travel arrangements.

Roxette’s current configuration includes co-founder Per Gessle and Swedish singer Lena Philipsson, who stepped in as lead vocalist following the passing of original singer Marie Fredriksson in 2019. Gessle expressed disappointment over the cancellations and emphasized that the decision was made by Live Nation USA, which appears to have been influenced by commercial considerations. He acknowledged the significance of the U.S. market for the band, especially given its prominence in their streaming audience.

The tour’s halt coincides with a wider trend in the live music industry, informally dubbed "blue dot fever." This term refers to the visual representation of unsold seats marked by blue dots on Ticketmaster's digital seating charts, symbolizing poor ticket sales that have led several artists to cancel or postpone shows. Roxette is among a growing list of performers affected by this phenomenon, including Post Malone, Meghan Trainor, and Zayn Malik, whose tours have faced cancellations or adjustments amid similar concerns.

Post Malone’s recent withdrawal from the initial leg of his stadium tour with Jelly Roll was officially attributed to studio commitments but was also rumored to stem from underwhelming ticket demand. Similarly, Meghan Trainor's decision to cancel her "Get in Girl" tour was publicly linked to her desire for family time after childbirth, although industry speculation pointed to tepid sales. Zayn Malik cited health issues for his tour interruptions, while reports suggested a lackluster market response as a contributing factor.

Live Nation, the leading concert promoter, has publicly refuted the "blue dot fever" narrative. CEO Michael Rapino has dismissed claims that declining ticket sales are widespread or that the company prioritizes high-priced premium tickets over affordability. He highlighted initiatives to offer reasonably priced tickets, including millions sold at $30, aiming to maintain accessibility for fans.

The unfolding situation with Roxette underscores ongoing challenges within the concert touring landscape, where escalating costs, fluctuating demand, and changing fan behaviors shape the viability of live events. The cancellation of a milestone tour for a band of Roxette’s stature signals potential shifts in market dynamics that both artists and promoters must navigate.

Details about any future rescheduling remain limited, though Roxette’s management has expressed hope to reconnect with North American audiences at a later date. For now, fans and industry observers watch closely as the implications of these cancellations ripple through the live music ecosystem.